All the news Showing 10 of 13 articles from: PrisonersGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources High hepatitis C reinfection rate in prison study highlights harm reduction needs Keith Alcorn / 20 April 2022 Hepatitis C reinfection rates were high in Australian prisoners who took part in a study of hepatitis C treatment in prisons, researchers from the University of New South Wales report in the ... Short stay in prison increases the risk of hepatitis C for people who use drugs Keith Alcorn / 03 September 2021 People who use drugs were over 50% more likely to acquire hepatitis C between 2004 and 2019 if they spent even a brief period in prison, a prospective study carried out in ... High hepatitis C cure rate achieved in New York prisons Keith Alcorn / 09 December 2020 Hepatitis C treatment in prisons can result in a high cure rate but people released from prison during treatment are less likely to be cured due to challenges in medication supply, continuity ... Is opt-out testing for HCV improving testing rates in UK prisons? Keith Alcorn / 04 April 2019 Testing rates for hepatitis C virus (HCV) in prisons in the United Kingdom remain far below the national minimum target of 50% and without radical change, prison testing rates will pose a ... Tackling HIV and hepatitis C in Europe: towards minimum standards Gus Cairns / 11 February 2019 Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in Bucharest featured discussions that could form the basis of a European-wide ... Recent incarceration increases HIV and hepatitis C risk for people who inject drugs Michael Carter / 19 November 2018 People who inject drugs (PWID) recently released from prison or jail have a substantially increased risk of acquiring infection with HIV or hepatitis C virus (HCV), according to the results of a systematic ... What are the barriers to hepatitis C treatment in prisons? Keith Alcorn / 15 October 2018 Lack of privacy, lack of peer support and lack of harm reduction are perceived as the biggest barriers to improving the uptake of direct-acting antiviral treatment for hepatitis C among prisoners, a qualitative ... Harm reduction measures for HCV prevention and treatment lacking in Europe's prisons, survey finds Keith Alcorn / 31 May 2018 Harm reduction measures for the prevention and treatment of hepatitis C in prisoners are still lacking in the majority of European countries and the lack of harm reduction will block ... Access to testing and treatment for hepatitis C in European prisons must improve Keith Alcorn / 30 May 2018 Lack of access to hepatitis C treatment and prevention in European prisons is a public health emergency and risks breaching international agreements on the avoidance of inhumane and degrading conditions, ... Australian experience shows that use of DAAs can virtually eliminate HCV among prisoners Michael Carter / 19 March 2018 Hepatitis C virus (HCV) infection can be rapidly eliminated in prison populations with the use of direct-acting antivirals (DAAs), results of an Australian study published in Clinical Infectious Diseases suggests. ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Human rights Stigma and discrimination Confidentiality, consent and medical ethics Prisoners Migrants Conference news Email bulletin archive